George Keefe

George Keefe served as SVP of Market Access and SVP of External Affairs and Public Policy during his 20 year career with Teva Pharmaceuticals. His leadership roles included Market Access, Government Affairs, Public Policy, Payer Marketing, Pricing and Contracting, Reimbursement Strategies, Patient Assistance and Medical Affairs. George served on Teva’s US and North America leadership teams from 2015 through 2021.

George joined Teva in 2002 where he took on various positions of increasing responsibility, assuming leadership of U.S. Market Access in 2015. George was involved with launching and commercializing dozens of products covering numerous therapeutic areas and digital health. In his most recent role, George led the Government Affairs, Public Policy and Medical Affairs functions. He helped to guide Teva’s advocacy efforts and represented Teva’s interests on a range of key issues. George worked with Congressional leaders, Members of Congress, key Administration officials and other policymakers on issues of critical importance to the industry.

George holds a Bachelor of Arts degree in Economics with a minor in Political Science from SUNY Geneseo and an MBA in Finance and Marketing from the University at Buffalo. He lives in Santa Rosa Beach, Florida with his wife Linda. George enjoys hiking, cycling, playing basketball and reading historical biographies of world leaders.

Miron is the Managing Director of Blackletter Group, a boutique life sciences consultancy helping senior executives find, assess and operationalize emerging science and nascent technologies at the intersection of digital and pharma. Prior to founding Blackletter, Miron was the VP of Innovation at LEO Pharma where he established digital health innovation labs in Toronto and Tel Aviv and co-headed LEO’s digital corporate VC arm. He acquired his passion for modernizing pharma while working at the Monitor Group (now Monitor Deloitte), where he led over 20 strategy projects with an eye to uncovering new growth opportunities for clients.
Miron is an alumnus of the University of Toronto (PhD in neuroscience), University of Massachusetts (MBA) and the Harvard Business School (Executive Education in Disruptive Innovation and Strategic Agility).

Uzi is a serial entrepreneur, longtime business executive and sales leader in the worlds of medical devices and digital health. After serving at multiple companies as a sales and marketing executive, Uzi managed Medcon, a leader in cardiology informatics, and was in charge of its growth from inception to a category leader, IPO, and sale to McKesson. At McKesson, Uzi acted as the VP cardiology.  Today, Uzi is the chief commercial officer for Tyto Care, a leading digital health startup in the field of remote patient monitoring. Uzi holds a BSC in computer science and mathematics MA in conflict resolution and MBA from Tel Aviv University.

Mr. Oldroyd has spent over 26 years in the healthcare industry.  His primary focus has been on startup organizations, building and executing business development and commercial strategies for new assets in therapeutics, diagnostics, real world data/AI engineering and software.  His expertise involves finding the best business use cases to generate revenue for new products in a large and challenging healthcare ecosystem.  He is currently the Chief Business Officer at C2i Genomics and sits on the Board of Directors at Base 10 Genetics.  Additionally, Mr. Oldroyd consults or advises a number of startup and larger organizations within the digital health, data security and diagnostic industries.  His education includes a Juris Doctor with a specialty in health law and policy.  Mr. Oldroyd spends much of his free time with his five adult children and two grandsons.  His other interests include aviation, as a private pilot, and adventure motorcycling.

Brad Fluegel was most recently the senior vice president – chief healthcare commercial market development officer for Walgreen Co., based in Deerfield, Ill. Previously, he was Chief Strategy and Business Development officer for Walgreens, responsible for corporate strategy and business development.

He joined Walgreens in October 2012 after previously serving as executive in residence at Health Evolution Partners. Before that he was executive vice president and chief strategy and external affairs officer of Wellpoint (now Anthem), among the nation’s largest health benefits companies.

Prior to Wellpoint, Brad was senior vice president of national accounts and vice president, enterprise strategy at Aetna, Inc. In this role, he led the national accounts business and was responsible for developing and executing on strategies that expanded Aetna’s position as a leader in the large employer market.

Earlier, Brad was CEO for Reden & Anders (Optum Consulting) and health sector leader at Tillinghast-Towers Perrin, a clinical, actuarial and management consulting practice that served all sectors of the health care industry.

Brad currently serves on the Board of Directors of MJHS Health System in New York City, Performant Financial Corporation, Premera Blue Cross, Itamar Medical and AdhereHealth. He also advises several health care companies and private equity firms.  He served on the Fitbit Board of Directors until its sale to Google in early 2021 and Alight Solutions until it’s merger in July of 2021.

Brad earned a master’s degree in public policy from Harvard University’s Kennedy School of Government and a bachelor of arts in business administration from the University of Washington. He also serves as a lecturer at the University of Pennsylvania’s Wharton School of Business.

Michael is an experienced telehealth entrepreneur, executive and advisor focused on combining emerging technology and business model innovation to commercialize and scale behavioral and population healthcare solutions. Over the past decade, he has raised over $30M from highly regarded venture funds – including .406 Ventures, Sandbox/BCBS Ventures, HLM, Canaan Partners and AXA Strategic Ventures – to start and grow two, technology-enabled healthcare services companies, Annum Health and AbleTo. In 2020, AbleTo was acquired by the nation’s largest health plan.

Currently, Michael serves as a board director at City Health Works (chairman), Medorion, wayForward, Wellth, and Project Health Minds (not for profit.) He is also an advisor to Intellihealth, Iris OB Health, CareTribe, Equip BH, and EMK Capital, a UK PE firm. Previously, he was an Entrepreneur-In-Residence (EIR) at Weill Cornell Medicine and has served on the board of Visiting Nurse Services of New York (2010-15). Prior to his entrepreneurial career, Michael worked at Furman Selz (investment banking), Bertelsmann, and McKinsey & Co.

Michael wrote Landing on the right Side of Your Ass, A Survival Guide for the Recently Unemployed (Three Rivers Press / Random House) and the “Hiring Line” columnist for BusinessWeek. He has a BA in political science from University of Chicago and an MBA from Harvard Business School. He lives with his wife in New York.

Adrienne is a retired American Airlines executive with over 20 years of corporate benefits, operations, and human resources experience.  During her career, she has developed deep expertise in identifying organizational needs matched with practical solutions. This experience includes evaluating hundreds of health care and health care technology companies and their ability to meet complex demands in a constantly evolving landscape.  She created an innovative, best-in-class ecosystem of health care and benefits programs for 100,000 employees of the world’s largest airline. She was accountable for oversight of challenging integrations from ideation through to execution.

She is the founder and CEO of The Camille Group, a strategic consulting firm.  Through her experience with working with sophisticated stakeholders in health care and employee benefits, her firm offers evidence-based solutions tailored to client needs.  The firm’s personalized and collaborative approach helps clients identify opportunities for revenue growth, strategies for effective operational execution, and provides ongoing advisory services to help ensure sustained success.

Moran Shochat-Snir leads the Emerging platforms and Data teams at Invitae (NVTA), a leading genetics company whose mission is to bring comprehensive genetic information into mainstream medicine. Moran is the co-founder and former CEO of Clear Genetics, which was acquired by Invitae in November 2019. Clear Genetics developed software to thoughtfully scale delivery of genetic services and integrate it into routine patient care. Prior, Moran was at Medtronic, where she held several key roles, including leading business strategy, portfolio prioritization, and business development. She was also the co-founder of MorNetware, an Israeli software company that scales delivery of prenatal carrier screening. Moran was an officer in Israel Defense Forces’ Elite software unit, then studied Biomedical Engineering at Tel Aviv University for her Bachelors and Masters Degrees. She has an MBA from the Wharton Business School and is a Y combinator Alum.

Josh is a health care product, operations and strategy leader with a 20-year track record of successfully creating, bringing to market, and selling employer-, payer- and provider-facing products at industry-leading healthcare companies. Josh’s areas of expertise include Medicare, telehealth, post-acute care, employer group benefits, complex disease management, product development and management, and finance.

Josh holds a BS in Nutritional Science from Cornell University and an MBA in Finance and Investments from the Zicklin School of Business (Baruch College, City University of New York)